Construct validity and parent–child agreement of the six new or modified disorders included in the Spanish version of the Kiddie Schedule for Affective Disorders and Schizophrenia present and Lifetime Version DSM-5 (K-SADS-PL-5)

Peña, Francisco R. de la; Rosetti, M.; Rodríguez-Delgado, Andrés; Villavicencio, Lino R.; Palacio, Juan David; Montiel, Cecilia; Mayer, Pablo A.; Félix, Fernando J.; Larraguibel, Marcela; Viola, Laura; Ortiz, Silvia; Fernández, Sofía Berlanga; Jaímes, Aurora; Feria, Miriam; Sosa, Liz; Palacios‐Cruz, Lino; Ulloa, Rosa Elena

doi:10.1016/j.jpsychires.2018.02.029

Cited by 23 publications

(15 citation statements)

References 40 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thus, future research should examine the psychometric properties of the computerized KSADS‐5 eating disorder diagnoses specifically. Also, while previous research has found acceptable parent‐child agreement for BED in the KSADS‐5 (de la Peña et al., 2018), other studies have found poor agreement between children and parent report using other assessment methods of eating disorder symptoms (Mariano, Watson, Leach, McCormack, & Forbes, 2013). This may be due, in part, to secrecy being a well‐documented facet of eating pathology (Kass et al., 2017) and, indeed inherent to diagnostic standards for binge eating (American Psychiatric Association, 2013).…”

Section: Discussionmentioning

confidence: 86%

Psychiatric comorbidity of eating disorders in children between the ages of 9 and 10

Convertino

Blashill

2021

Child Psychology Psychiatry

View full text Add to dashboard Cite

Background Eating disorders exhibit high comorbidity with other psychiatric disorders, most notably mood, substance use, and anxiety disorders. However, most studies examining psychiatric comorbidity are conducted in adolescents and adults. Therefore, the comorbidity among children living with eating disorders is unknown. The aim of this study was to characterize co‐occurring psychiatric disorders with eating disorders in a US sample of children aged 9–10 years old utilizing the Adolescent Brain Cognitive Development study. Methods The analytic sample included 11,718 children aged 9–10 years. Anorexia nervosa, bulimia nervosa, binge eating disorder, and other specified feeding and eating disorder subtype diagnoses were examined. Statistical analyses were conducted using complex sampling. Odds ratios and 95% confidence intervals were calculated comparing the likelihood of being diagnosed for a psychiatric disorder when having an eating disorder, as compared to children without an eating disorder, children diagnosed with major depressive disorder, and children diagnosed with posttraumatic stress disorder using binary logistic regression. Results Co‐occurring psychiatric disorders were substantially higher in children with eating disorders as compared to children without eating disorders, but not as compared to children diagnosed with major depressive disorder or posttraumatic stress disorder. The most common comorbidities for the eating disorder group were anxiety disorders (71.4%), attention deficit/hyperactivity disorder (47.9%), disruptive/impulse control disorders (45.0%), mood disorders (29.6%), and obsessive‐compulsive disorder (28.8%), largely in line with previous research. Conclusions This study extends prior research finding high rates of comorbidity in eating disorders, specifically with anxiety, mood, and disruptive/impulse control disorders. Clinicians assessing for psychiatric disorders should be aware that eating disorders can occur in children 9 and 10 years old and are associated with severe comorbidity. Referrals for specialty mental health care should be considered.

show abstract

Section: Discussionmentioning

confidence: 86%

Psychiatric comorbidity of eating disorders in children between the ages of 9 and 10

Convertino

Blashill

2021

Child Psychology Psychiatry

View full text Add to dashboard Cite

show abstract

“…They presented a median number of comorbid diagnoses per patient of 3 (1–5.75). Complete demographic and diagnostic clinical characteristics of the sample can be reviewed in a previous report [ 24 ].…”

Section: Resultsmentioning

confidence: 99%

Validity and reliability of the kiddie schedule for affective disorders and schizophrenia present and lifetime version DSM-5 (K-SADS-PL-5) Spanish version

et al. 2018

Self Cite

View full text Add to dashboard Cite

BackgroundThere are various language adaptations of the Schedule for Affective Disorders and Schizophrenia for School Age Children Present and Lifetime Version (K-SADS-PL). In order to comply with the changes in DSM classification, the Spanish edition of the interview was in need of update and evaluation.MethodsK-SADS-PL was adapted to correspond to DSM-5 categories. All clinicians received training, and a 90% agreement was reached. Patients and their parents or guardians were interviewed and videotaped, and the videos were exchanged between raters. Factor analysis was performed and inter-rater reliability was calculated only in the case of diagnoses in which there were more than five patients.ResultsA total of 74 subjects were included. The Factor Analysis yielded six factors (Depressive, Stress Hyperarousal, Disruptive Behavioral, Irritable Explosive, Obsessive Repetitive and Encopresis), representing 72% of the variance. Kappa values for inter-rater agreement were larger than 0.7 for over half of the disorders.ConclusionsThe factor structure of diagnoses, made with the instrument was found to correspond to the DSM-5 disorder organization. The instrument showed good construct validity and inter-rater reliability, which makes it a useful tool for clinical research studies in children and adolescents.Electronic supplementary materialThe online version of this article (10.1186/s12888-018-1773-0) contains supplementary material, which is available to authorized users.

show abstract

“…At Waves 2 and 3, we will screen for only MDD, persistent depressive disorder, and eating disorders. The KSADS-PL has been shown to have good inter-rater reliability, construct validity and predictive validity in children and adolescents [ 59 , 60 ].…”

Section: Methodsmentioning

confidence: 99%

Assessing the role of adolescent hormonal contraceptive use on risk for depression: a 3-year longitudinal study protocol

et al. 2022

View full text Add to dashboard Cite

Background The incidence of depression in human females rises steadily throughout adolescence, a critical period of pubertal maturation marked by increasing levels of gonadal hormones including estrogens and progesterone. These gonadal hormones play a central role in social and emotional development and may also contribute to the increased occurrence of depression in females that begins in early adolescence. In this study, we examine whether and how introducing synthetic estrogen and progestin derivatives through the use of combined hormonal contraceptives (CHC), affects adolescent females’ risk for developing depression. We further assess potential links between CHC use and alterations in stress responses and social-emotional functioning. Methods Using a longitudinal cohort design, we will follow a sample of adolescent females over the span of three years. Participants will be assessed at three time points: once when they are between 13 and 15 years of age, and at approximately 18 and 36 months after their initial assessment. Each time point will consist of two online sessions during which participants will complete a clinical interview that screens for key symptoms of mental health disorders, along with a series of questionnaires assessing their level of depressive symptoms and history of contraceptive use. They will also complete a standardized social-evaluative stress test and an emotion recognition task, as well as provide saliva samples to allow for assessment of their circulating free cortisol levels. Discussion In this study we will assess the effect of CHC use during adolescence on development of Major Depressive Disorder (MDD). We will control for variables previously found to or proposed to partially account for the observed relationship between CHC use and MDD, including socioeconomic status, age of sexual debut, and CHC-related variables including age of first use, reasons for use, and its duration. In particular, we will discover whether CHC use increases depressive symptoms and/or MDD, whether elevated depressive symptoms and/or MDD predict a higher likelihood of starting CHC, or both. Furthermore, this study will allow us to clarify whether alterations in stress reactivity and social-emotional functioning serve as pathways through which CHC use may result in increased risk of depressive symptoms and/or MDD.

show abstract

Construct validity and parent–child agreement of the six new or modified disorders included in the Spanish version of the Kiddie Schedule for Affective Disorders and Schizophrenia present and Lifetime Version DSM-5 (K-SADS-PL-5)

Cited by 23 publications

References 40 publications

Psychiatric comorbidity of eating disorders in children between the ages of 9 and 10

Psychiatric comorbidity of eating disorders in children between the ages of 9 and 10

Validity and reliability of the kiddie schedule for affective disorders and schizophrenia present and lifetime version DSM-5 (K-SADS-PL-5) Spanish version

Assessing the role of adolescent hormonal contraceptive use on risk for depression: a 3-year longitudinal study protocol

Contact Info

Product

Resources

About